APA (7th ed.) Citation

Klavdianou, K., Melissaropoulos, K., Filippopoulou, A., & Daoussis, D. (2021). Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A.

Chicago Style (17th ed.) Citation

Klavdianou, Kalliopi, Konstantinos Melissaropoulos, Alexandra Filippopoulou, and Dimitrios Daoussis. Should We Be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A, 2021.

MLA (8th ed.) Citation

Klavdianou, Kalliopi, et al. Should We Be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A, 2021.